NLS

AstraZeneca’s global biologics R&D arm MedImmune has acquired AlphaCorePharma. The Michigan-based biotech company focuses on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. Cardiovascular and metabolic disease is a core therapy area for AstraZeneca’s small and large molecule research. “As the science in this area continues to evolve, we are committed to […]

Danish Bavarian Nordic receives contract valued up to USD 228 Million from the U.S. Government.

Novo Nordisk teams up with Kymab in an antibody discovery agreement.

According to new report, produced Ministry of Employment and the Economy, Finland’s private pharmaceutical research sector could more than double in size by the year 2020. For a long time, Finland has been a popular location for pharmaceutical research. However, in recent years the number of clinical research projects has fallen as companies have moved […]

In order to attract more foreign investors to finding partners in Stockholm and Uppsala, the business region is launching a top list with the hottest investment prospects. The Stockholm-Uppsala Life Science Investment Hotlist will present the most attractive and interesting companies from the region. “The overriding objective is to make the companies visible among the […]

In mid-February, two hundred researchers from academia and industry gathered in Uppsala for a meeting on diagnostics, as part of the Swedish Life Science Investment Year. Interest in cost-effective, reliable diagnostic tests is increasing worldwide. Healthcare providers and financiers are increasingly looking to state-of-the-art diagnostics for new tools to aid physicians in making informed decisions […]